Gilder Gagnon Howe & CO LLC Insulet Corp Transaction History
Gilder Gagnon Howe & CO LLC
- $7.87 Billion
- Q3 2024
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Insulet Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 10,082 shares of PODD stock, worth $2.67 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,082
Previous 10,122
0.4%
Holding current value
$2.67 Million
Previous $2.04 Million
14.89%
% of portfolio
0.03%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.6MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.25 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.06 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.61 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$773 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$603 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.4B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...